Considering their fast surge to ubiquity in beverages, it can be easy to forget at times that THC and CBD are merely two of over 100 (so far) identified cannabinoids that exist in the cannabis plant. Those other compounds — CBG, CBN, CBC and CBL, to name some — may not be household names quite yet, but if they come anywhere close to the projections for the CBD market (approximately $24 billion by 2023), then they are certainly going to be big.

At least, that’s what Texas-based hemp supplier Socati is betting on. The company is aiming to set itself up as a long-term player in the space by focusing on creating custom minor cannabinoid profiles for its clients through the launch of a new full-service private label division capable of producing a variety of products, including gummies, tinctures, capsules, tablets and crystalized flavored powdered that can be added to liquids or consumed orally.

Read the full BevNET article here.